Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

HIGHLIGHTS

• who: Yun Liu from the (UNIVERSITY) have published the research: Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy, in the Journal: (JOURNAL)
• what: Perspective, the research progress of dualtarget VEGFR inhibitors is summarized, focusing on the rational targets selection, structure-activity relationships (SARs) and pharmacological activities of dual-target VEGFR inhibitors. This approach is characterized by integrating the potency of two selective inhibitors into a single molecule and is carried out by linking or merging the pivotal pharmacophores of selected maternal inhibitors.
• how: As shown . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.